日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細


公開

学術論文

GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway

MPS-Authors

Edwards-Hicks,  Joy
Department Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

/persons/resource/persons201431

Pearce,  Erika Laine
Department Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

External Resource
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
フルテキスト (公開)
公開されているフルテキストはありません
付随資料 (公開)
There is no public supplementary material available
引用

Park, A. Y., Leney-Greene, M., Lynberg, M., Gabrielski, J. Q., Xu, X., Schwarz, B., Zheng, L., Balasubramaniyam, A., Ham, H., Chao, B., Zhang, Y., Matthews, H. F., Cui, J., Yao, Y., Kubo, S., Chanchu, J. M., Morawski, A. R., Cook, S. A., Jiang, P., Ravell, J. C., Cheng, Y. H., George, A., Faruqi, A., Pagalilauan, A. M., Bergerson, J. R. E., Ganesan, S., Chauvin, S. D., Aluri, J., Edwards-Hicks, J., Bohrnsen, E., Tippett, C., Omar, H., Xu, L., Butcher, G. W., Pascall, J., Karakoc-Aydiner, E., Kiykim, A., Maecker, H., Tezcan, İ., Esenboga, S., Heredia, R. J., Akata, D., Tekin, S., Kara, A., Kuloglu, Z., Unal, E., Kendirli, T., Dogu, F., Karabiber, E., Atkinson, T. P., Cochet, C., Filhol, O., Bosio, C. M., Davis, M. M., Lifton, R. P., Pearce, E. L., Daumke, O., Aytekin, C., Şahin, G. E., Aksu, A. Ü., Uzel, G., Rao, V. K., Sari, S., Boztug, K., Cagdas, D., Haskologlu, S., Ikinciogullari, A., Schwefel, D., Vilarinho, S., Baris, S., Ozen, A., Su, H. C., & Lenardo, M. J. (2024). GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway. Nature Immunology. doi:10.1038/s41590-023-01691-y.


引用: https://hdl.handle.net/21.11116/0000-000E-398B-6
要旨
Preserving cells in a functional, non-senescent state is a major goal for extending human healthspans. Model organisms reveal that longevity and senescence are genetically controlled, but how genes control longevity in different mammalian tissues is unknown. Here, we report a new human genetic disease that causes cell senescence, liver and immune dysfunction, and early mortality that results from deficiency of GIMAP5, an evolutionarily conserved GTPase selectively expressed in lymphocytes and endothelial cells. We show that GIMAP5 restricts the pathological accumulation of long-chain ceramides (CERs), thereby regulating longevity. GIMAP5 controls CER abundance by interacting with protein kinase CK2 (CK2), attenuating its ability to activate CER synthases. Inhibition of CK2 and CER synthase rescues GIMAP5-deficient T cells by preventing CER overaccumulation and cell deterioration. Thus, GIMAP5 controls longevity assurance pathways crucial for immune function and healthspan in mammals.